Journal of Diagnostics Concepts & Practice >
Interpretation on the report of global stroke data 2022
Received date: 2023-05-08
Online published: 2023-11-17
In 2022, the World Stroke Organization released two new reports regarding global stroke statistics in the International Journal of Stroke. The reports updated the global incidence and mortality of stroke, evaluated the effects of gender and geographic factors, and provided updated statistics on attributable risk factors associated with stroke. This article briefly interprets the two reports in the context of stroke prevalence and disease burden in China. 2019 Global Burden of Disease Study findings show that stroke remains the second-leading cause of death and the third-leading cause of death and disability combined in the world. From 1990 to 2019, the burden (in terms of the absolute number of cases) increased substantially, with the bulk of the global stroke burden residing in lower-income and lower-middle-income countries. Moreover, people under 70-year-old were observed to have significant increases in stroke prevalence and incidence. The five major risks for stroke globally include high systolic blood pressure, high body mass index, high fasting glucose, environmental particulate matter pollution, and smoking. Stroke prevention and treatment in China are facing great challenges. Stroke has become the leading cause of death and disability among Chinese adults, as well as the leading cause of disability adjusted life year lost. The incidence, prevalence and mortality of stroke in China are geographically high in the north, low in the south and prominent in the central part of the country; the prevalence is higher in rural areas than that in urban areas; the morbidity and mortality rates are higher in men than those in women; the average age of onset is lower than in developed countries; the overall disease burden of ischemic stroke is on the rise, but that of hemorrhagic stroke is on the decline. The awareness of stroke prevention and treatment was low. In conclusion, it is of strategic importance to actively establish a graded stroke prevention and control system that meets the national conditions.
Key words: Stroke; Incidence; Mortality; Global burden of disease
TANG Chunhua, GUO Lu, LI Qiong, ZHANG Lili . Interpretation on the report of global stroke data 2022[J]. Journal of Diagnostics Concepts & Practice, 2023 , 22(03) : 238 -246 . DOI: 10.16150/j.1671-2870.2023.03.06
[1] | FEIGIN V L, BRAININ M, NORRVING B, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022[J]. Int J Stroke, 2022, 17(1):18-29. |
[2] | THAYABARANATHAN T, KIM J, CADILHAC D A, et al. Global stroke statistics 2022[J]. Int J Stroke, 2022, 17(9):946-956. |
[3] | 王拥军, 李子孝, 谷鸿秋, 等. 中国卒中报告2020(中文版)(1)[J]. 中国卒中杂志, 2022, 17(5):433-447. |
[3] | WANG Y J, LI Z X, GU H Q, et al. China Stroke Statistics 2020 (1)[J]. Chin J Stroke, 2022, 17(5):433-447. |
[4] | 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4):20-36,40. |
[4] | The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary[J]. Prev Treat Cardio-Cereb-Vasc Dis, 2022, 22(4):20-36,40. |
[5] | GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol, 2021, 20(10):795-820. |
[6] | OWOLABI M O, THRIFT A G, MAHAL A, et al. Primary stroke prevention worldwide: translating evidence into action[J]. Lancet Public Health, 2022, 7(1):e74-e85. |
[7] | MA Q, LI R, WANG L, et al. Temporal trend and attribu-table risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12):e897-e906. |
[8] | LIU Z, LI Y H, CUI Z Y, et al. Prevalence of tobacco dependence and associated factors in China: Findings from nationwide China Health Literacy Survey during 2018-19[J]. Lancet Reg Health West Pac, 2022, 24:100464. |
[9] | GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 393(10184):1958-1972. |
[10] | HE J, OGDEN L G, VUPPUTURI S, et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults[J]. JAMA, 1999, 282(21):2027-2034. |
[11] | 《中国居民膳食指南科学研究报告(2021)》简介[J]. 营养学报, 2021, 43(1):1-2. |
[11] | Reprort of Scientific Research on Chinese Dietary Guidelines (2021)[J]. Acta Nutrimenta Sin, 2021, 43(1):1-2. |
[12] | ZHANG L, HUANG L, WEIGER C, et al. Prevalence, correlates, and behavioral outcomes of alcohol gifting in China[J]. BMC Public Health, 2022, 22(1):1653. |
[13] | 王拥军, 李子孝, 谷鸿秋, 等. 中国卒中报告2019(中文版)(1)[J]. 中国卒中杂志, 2020, 15(10):1037-1043. |
[13] | WANG Y J, LI Z X, GU H Q, et al. China Stroke Statistics 2019 (1)[J]. Chin J Stroke, 2020, 15(10):1037-1043. |
[14] | WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(7):446-461. |
[15] | HOWARD V J, MCDONNELL M N. Physical activity in primary stroke prevention: just do it![J]. Stroke, 2015, 46(6):1735-1739. |
[16] | CAO J, ESHAK E S, LIU K, et al. An age-period-cohort analysis of stroke mortality attributable to low physical activity in China and Japan: data from the GBD study 1990-2016[J]. Sci Rep, 2020, 10(1):6525. |
[17] | MURPHY R P, REDDIN C, ROSENGREN A, et al. Depressive symptoms and risk of acute stroke: INTERSTROKE case-control study[J]. Neurology, 2023, 100(17):e1787-e1798. |
[18] | LU J, XU X, HUANG Y, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2021, 8(11):981-990. |
[19] | 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56. |
[19] | Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al. 2018 Chinese guidelines for the management of hypertension Writing Group of 2018[J]. Chin J Cardiovasc Med, 2019, 24(1):24-56. |
[20] | LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369:m997. |
[21] | YAGHI S, ELKIND M S. Lipids and cerebrovascular di-sease: research and practice[J]. Stroke, 2015, 46(11):3322-3328. |
[22] | SONG P K, MAN Q Q, LI H, et al. Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015[J]. Biomed Environ Sci, 2019, 32(8):559-570. |
[23] | OLADIRAN O, NWOSU I. Stroke risk stratification in atrial fibrillation: a review of common risk factors[J]. J Community Hosp Intern Med Perspect, 2019, 9(2):113-120. |
[24] | DU X, GUO L, XIA S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7):535-541. |
[25] | JACOB M A, EKKER M S, ALLACH Y, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-a worldwide meta-analysis: the GOAL initiative[J]. Neurology, 2022, 98(6):e573-e588. |
[26] | LACKLAND D T, ROCCELLA E J, DEUTSCH A F, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(1):315-353. |
[27] | YAO M, REN Y, JIA Y, et al. Projected burden of stroke in China through 2050[J]. Chin Med J (Engl), 2023, 136(13):1598-1605. |
[28] | LUO Y, SU B, ZHENG X. et al. Trends and challenges for population and health during population aging - China, 2015-2050[J]. China CDC Wkly, 2021, 3(28):593-598. |
[29] | RU X, WANG W, SUN H, et al. Geographical difference, rural-urban transition and trend in stroke prevalence in China: findings from a national epidemiological survey of stroke in China[J]. Sci Rep, 2019, 9(1):17330. |
[30] | TU W J, ZHAO Z, YIN P, et al. Estimated burden of stroke in China in 2020[J]. JAMA Netw Open, 2023, 6(3):e231455. |
[31] | ORNELLO R, DEGAN D, TISEO C, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis[J]. Stroke, 2018, 49(4):814-819. |
[32] | WU S, WU B, LIU M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405. |
[33] | LIANG J, LUO C, KE S, et al. Stroke related knowledge, prevention practices and associated factors among stroke patients in Taizhou, China[J]. Prev Med Rep, 2023, 35:102340. |
/
〈 |
|
〉 |